Osteosarcomagenesis: Modeling cancer initiation in the mouse

Sarcoma

Volumn 2011, Issue , 2011, Pages

  Jones, Kevin B ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABELSON KINASE; CALCIUM 45; CARCINOGEN; COLLAGENASE 3; NEURONAL APOPTOSIS INHIBITORY PROTEIN; OSTEOCLAST DIFFERENTIATION FACTOR; PROTEIN P53; RADIOISOTOPE; RETINOBLASTOMA BINDING PROTEIN 1; TRANSCRIPTION FACTOR RUNX2; XERODERMA PIGMENTOSUM GROUP D PROTEIN;

BONE DEVELOPMENT; BONE MARROW CELL; BONE MINERALIZATION; CANCER INCIDENCE; CANCER MODEL; CARCINOGENESIS; CELL DIFFERENTIATION; CHEMICAL MUTAGENESIS; CHROMOSOMAL INSTABILITY; DNA DAMAGE; ENVIRONMENTAL EXPOSURE; GENE DELETION; GENE EXPRESSION; GENE LOCUS; GENE MUTATION; GENE SILENCING; GENE TARGETING; GERMLINE MUTATION; HETEROZYGOSITY; HOMOZYGOSITY; LEUKEMIA; LYMPHOMA; MESENCHYMAL STEM CELL; METASTASIS; MICROSATELLITE INSTABILITY; NONHUMAN; ONCOGENE C FOS; ONCOGENE C JUN; ONCOGENE K RAS; OSTEOBLAST; OSTEOSARCOMA; OSTEOSARCOMAGENESIS; PRIORITY JOURNAL; RADIATION EXPOSURE; RADIATION INDUCED NEOPLASM; RADIATION MUTAGENESIS; REVIEW; TRANSPOSON; TUMOR SUPPRESSOR GENE;

EID: 79953290301     PISSN: 1357714X     EISSN: 13691643     Source Type: Journal    
DOI: 10.1155/2011/694136     Document Type: Review

References (92)

1. Damron T. A., Ward W. G., Stewart A., Osteosarcoma, chondrosarcoma, and Ewing's sarcoma: national cancer data base report Clinical Orthopaedics and Related Research 2007 459 40 47 (Pubitemid 46878192)
2. Unni K. K., Dahlin D. C., Osteosarcoma: pathology and classification Seminars in Roentgenology 1989 24 3 143 152 (Pubitemid 19173448)
3. Marina N., Gebhardt M., Teot L., Gorlick R., Biology and therapeutic advances for pediatric osteosarcoma Oncologist 2004 9 4 422 441 (Pubitemid 39014554)
4. Kurt A. M., Unni K. K., McLeod R. A., Pritchard D. J., Low-grade intraosseous osteosarcoma Cancer 1990 65 6 1418 1428 (Pubitemid 20097173)
5. Pybus F. C., Miller E. W., Spontaneous bone tumours of mice American Journal of Cancer 1938 33 98 111
6. Brunschwig A., Bissell A. D., Production of osteosarcoma in a mouse by the intramedullary injection of 1,2-Benzpyrene Archives of Surgery 1938 53 60
7. Brunschwig A., Production of primary bone tumors (Fibrosarcoma of Bone) by intramedullary injection of methylcholanthrene American Journal of Cancer 1938 34 540 542
8. Moritani M., DMBA induced fibrosarcoma in bone. Histochemical and electron microscopical studies on new transplantable bone tumor of 72 dimethylbenz()anthracene induced fibrosarcoma in rats Neoplasma 1977 24 2 165 176 (Pubitemid 8089954)
9. Sato K., Nukaga H., Horikoshi T., Iwasaki I., Difference in the induction of osteosarcoma in rabbit bone with single administration of three kinds of chemical carcinogens Gann 1978 69 4 579 583 (Pubitemid 9008264)
10. Devens B. H., Lundak R. L., Byus C. V., Induction of murine fibrosarcomas by low dose treatment with 3-methylcholanthrene followed by promotion with 12-O-tetradecanoyl-phorbol-13-acetate Cancer Letters 1984 21 3 317 324 (Pubitemid 14158507)
11. Breivik J., Gaudernack G., Genomic instability, DNA methylation, and natural selection in colorectal carcinogenesis Seminars in Cancer Biology 1999 9 4 245 254 (Pubitemid 29429989)
12. Kristensen P., Andersen A., Irgens L. M., Bye A. S., Sundheim L., Cancer in offspring of parents engaged in agricultural activities in Norway: incidence and risk factors in the farm environment International Journal of Cancer 1996 65 1 39 50 (Pubitemid 26027537)
13. Merletti F., Richiardi L., Bertoni F., Ahrens W., Buemi A., Costa-Santos C., Eriksson M., Gunel P., Kaerlev L., Jckel K. H., Llopis-Gonzalez A., Merler E., Miranda A., Morales-Surez-Varela M. M., Olsson H., Fletcher T., Olsen J., Occupational factors and risk of adult bone sarcomas: a multicentric case-control study in Europe International Journal of Cancer 2006 118 3 721 727 (Pubitemid 43076023)
14. Martland H. S., The occurrence of malignancy in radioactive persons American Journal of Cancer 1931 15 2435 2516
15. Sabin F. R., Doan C. A., Forkner C. E., The production of osteogenic sarcomata and the effects on lymph nodes and bone marrow of intravenous injections of radium chloride and mesothorium in rabbits The Journal of Experimental Medicine 1932 56 267 289
16. Ross J., Carcinogenic action of radium in the rabbit: effect of prolonged irradiation with screened radium The Journal of Pathology and Bacteriology 1936 43 267 276
17. Selbie F. R., Tumours in rats and mice following the injection of thorotrast British Journal of Experimental Pathology 1938 19 100 107
18. Sutro C. J., Pomerantz L., Effect of experimentally formed tumors on the musculoskeletal system of the rat Archives of Surgery 1939 38 1132 1149
19. Goessner W., Hug O., Luz A., Mueller W. A., Experimental induction of bone tumors by short lived bone seeking radionuclides Recent Results in Cancer Research 1976 54 36 49
20. Hori C. G., Warren S., Patterson W. B., Chute R. N., Gamma-ray induction of malignant tumors in rats American Journal of Pathology 1971 65 2 279 292
21. Arlen M., Higinbotham N. L., Huvos A. G., Marcove R. C., Miller T., Shah I. C., Radiation-induced sarcoma of bone Cancer 1971 28 5 1087 1099
22. Heidenreich W. F., Mller W. A., Paretzke H. G., Rosemann M., Bone cancer risk in mice exposed to 224Ra: protraction effects from promotion Radiation and Environmental Biophysics 2005 44 1 61 67 (Pubitemid 40896718)
23. Tomita K., Experimental studies on high-dose methotrexate with citrovorum factor chemotherapy for Sr-induced osteosarcoma murine model Japanese Journal of Antibiotics 1986 39 5 1219 1227 (Pubitemid 16063136)
24. Blair H. A., Radiation dose-time relations for induction of osteosarcoma in mice and dogs and their bearing on maximal permissible burden of 90 Sr in man Health Physics 1972 23 6 759 765
25. Thorne M. C., Aspects of the dosimetry of alpha-emitting radionuclides in bone with particular emphasis on 226Ra and 239Pu Physics in Medicine and Biology 1977 22 1, article 005 36 46 (Pubitemid 8031423)
26. Argyris B. F., Reif A. E., Lack of suppressor cell activity in the spleens of mice with radiation-induced osteogenic sarcomas Cancer Research 1981 41 3 839 844 (Pubitemid 11136322)
27. Nilsson A., Bierke P., Broome-Karlsson A., Induction of neoplasia by 140Ba in mice Acta Radiologica 1980 19 4 293 297
28. Humphreys E. R., Loutit J. F., Stones V. A., The induction by 239Pu of myeloid leukaemia and osteosarcoma in female CBA mice. International Journal of Radiation Biology 1987 51 2 331 339 (Pubitemid 17041646)
29. Luz A., Mller W. A., Schffer E., Murray A. B., Linzner U., Gssner W., The sensitivity of female NMRI mice of different ages for osteosarcoma induction with 227thorium Strahlentherapie. Sonderbande 1985 80 178 182 (Pubitemid 16151480)
30. Mller W. A., Luz A., Schffer E. H., Gssner W., The role of time-factor and RBE for the induction of osteosarcomas by incorporated short-lived bone-seekers Health Physics 1983 44 203 212
31. Uren A. G., Kool J., Berns A., Van Lohuizen M., Retroviral insertional mutagenesis: past, present and future Oncogene 2005 24 52 7656 7672 (Pubitemid 41670669)
32. Van Ree J. H., Jeganathan K. B., Malureanu L., Van Deursen J. M., Overexpression of the E2 ubiquitin-conjugating enzyme UbcH10 causes chromosome missegregation and tumor formation Journal of Cell Biology 2010 188 1 83 100
33. Baker D. J., Jeganathan K. B., Malureanu L., Perez-Terzic C., Terzic A., Van Deursen J. M. A., Early aging-associated phenotypes in Bub3/Rae1 haploinsufficient mice Journal of Cell Biology 2006 172 4 529 540 (Pubitemid 43243874)
34. Dawlaty M. M., Malureanu L., Jeganathan K. B., Kao E., Sustmann C., Tahk S., Shuai KE., Grosschedl R., van Deursen J. M., Resolution of sister centromeres requiresRanBP2-mediated SUMOylation of topoisomerase II Cell 2008 133 1 103 115 (Pubitemid 351442988)
35. Jeganathan K., Malureanu L., Baker D. J., Abraham S. C., Van Deursen J. M., Bub1 mediates cell death in response to chromosome missegregation and acts to suppress spontaneous tumorigenesis Journal of Cell Biology 2007 179 2 255 267 (Pubitemid 350004890)
36. Baker D. J., Jin F., Jeganathan K. B., van Deursen J. M., Whole chromosome instability caused by Bub1 insufficiency drives tumorigenesis through tumor suppressor gene loss of heterozygosity Cancer Cell 2009 16 6 475 486
37. Collier L. S., Adams D. J., Hackett C. S., Bendzick L. E., Akagi K., Davies M. N., Diers M. D., Rodriguez F. J., Bender A. M., Tieu C., Matise I., Dupuy A. J., Copeland N. G., Jenkins N. A., Hodgson J. G., Weiss W. A., Jenkins R. B., Largaespada D. A., Whole-body sleeping beauty mutagenesis can cause penetrant leukemia/lymphoma and rare high-grade glioma without associated embryonic lethality Cancer Research 2009 69 21 8429 8437
38. Collier L. S., Carlson C. M., Ravimohan S., Dupuy A. J., Largaespada D. A., Cancer gene discovery in solid tumours using transposon-based somatic mutagenesis in the mouse Nature 2005 436 7048 272 276 (Pubitemid 41021279)
39. Finkel M. P., Reilly C. A., Biskis B. O., Pathogenesis of radiation and virus induced bone tumors Recent Results in Cancer Research 1976 54 92 103
40. Curran T., Peters G., Van Beveren C., FBJ murine osteosarcoma virus: identification and molecular cloning of biologically active proviral DNA Journal of Virology 1982 44 2 674 682 (Pubitemid 13199900)
41. Curran T., Verma I. M., FBR murine osteosarcoma virus. I. Molecular analysis and characterization of a 75,000-Da gag-fos fusion product Virology 1984 135 1 218 228 (Pubitemid 14122262)
42. Ruther U., Komitowski D., Schubert F. R., Wagner E. F., c-fos expression induces bone tumors in transgenic mice Oncogene 1989 4 7 861 865 (Pubitemid 19176973)
43. Wang Z. Q., Liang J., Schellander K., Wagner E. F., Grigoriadis A. E., c-fos-induced osteosarcoma formation in transgenic mice: cooperativity with c-jun and the role of endogenous c-fos Cancer Research 1995 55 24 6244 6251
44. Schon A., Michiels L., Janowski M., Expression of protooncogenes in murine osteosarcomas International Journal of Cancer 1986 38 1 67 74 (Pubitemid 16056260)
45. Schmidt J., Heermeier K., Linzner U., Luz A., Silbermann M., Livne E., Erfle V., Osteosarcomagenic doses of radium (224Ra) and infectious endogenous retroviruses enhance proliferation and osteogenic differentiation of skeletal tissue differentiating in vitro Radiation and Environmental Biophysics 1994 33 1 69 79 (Pubitemid 24106695)
46. Lloyd E. L., Loutit J. F., Mackevicius F., Mackevicius, Viruses in osteosarcomas induced by 226Ra. A study of the induction of bone tumours in mice International Journal of Radiation Biology 1975 28 1 13 33
47. Ou MA., Cai W. W., Zender L., Dayaram T., Shen J., Herron A. J., Lowe S. W., Man T. K., Lau C. C., Donehower L. A., MMP13, Birc2 (clAP1), and Birc3 (clAP2), amplified on chromosome 9, collaborate with p53 deficiency in mouse osteosarcoma progression Cancer Research 2009 69 6 2559 2567
48. Khanna C., Wan X., Bose S., Cassaday R., Olomu O., Mendoza A., Yeung C., Gorlick R., Hewitt S. M., Helman L. J., The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis Nature Medicine 2004 10 2 182 186 (Pubitemid 38524889)
49. Marton I., Johnson S. E., Damjanov I., Currier K. S., Sundberg J. P., Knowles B. B., Expression and immune recognition of SV40 Tag in transgenic mice that develop metastatic osteosarcomas Transgenic Research 2000 9 2 115 125 (Pubitemid 30610229)
50. Wilkie T. M., Schmidt R. A., Baetscher M., Messing A., Smooth muscle and bone neoplasms in transgenic mice expressing SV40 T antigen Oncogene 1994 9 10 2889 2895 (Pubitemid 24296763)
51. Jensen N. A., Rodriguez M. L., Garvey J. S., Miller C. A., Hood L., Transgenic mouse model for neurocristopathy: schwannomas and facial bone tumors Proceedings of the National Academy of Sciences of the United States of America 1993 90 8 3192 3196 (Pubitemid 23111331)
52. Knowles B. B., McCarrick J., Fox N., Solter D., Damjanov I., Osteosarcomas in transgenic mice expressing an -amylase-SV40 T-antigen hybrid gene American Journal of Pathology 1990 137 2 259 262 (Pubitemid 20232987)
53. Walkley C. R., Qudsi R., Sankaran V. G., Perry J. A., Gostissa M., Roth S. I., Rodda S. J., Snay E., Dunning P., Fahey F. H., Alt F. W., McMahon A. P., Orkin S. H., Conditional mouse osteosarcoma, dependent on p53 loss and potentiated by loss of Rb, mimics the human disease Genes and Development 2008 22 12 1662 1676 (Pubitemid 351846845)
54. Berman S. D., Calo E., Landman A. S., Danielian P. S., Miller E. S., West J. C., Fonhoue B. D., Caron A., Bronson R., Bouxsein M. L., Mukherjee S., Lees J. A., Metastatic osteosarcoma induced by inactivation of Rb and p53 in the osteoblast lineage Proceedings of the National Academy of Sciences of the United States of America 2008 105 33 11851 11856
55. Jacks T., Remington L., Williams B. O., Schmitt E. M., Halachmi S., Bronson R. T., Weinberg R. A., Tumor spectrum analysis in p53-mutant mice Current Biology 1994 4 1 1 7
56. Li F. P., Fraumeni J. F., Mulvihill J. J., Blattner W. A., Dreyfus M. G., Tucker M. A., Miller R. W., A cancer family syndrome in twenty-four kindreds Cancer Research 1988 48 18 5358 5362
57. Olive K. P., Tuveson D. A., Ruhe Z. C., Yin B., Willis N. A., Bronson R. T., Crowley D., Jacks T., Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome Cell 2004 119 6 847 860 (Pubitemid 40017690)
58. Lengner C. J., Steinman H. A., Gagnon J., Smith T. W., Henderson J. E., Kream B. E., Stein G. S., Lian J. B., Jones S. N., Osteoblast differentiation and skeletal development are regulated by Mdm2-p53 signaling Journal of Cell Biology 2006 172 6 909 921
59. Clarke A. R., Robanus Maandag E., Van Roon M., Van Der Lugt N. M. T., Van Der Valk M., Hooper M. L., Berns A., Te Riele H., Requirement for a functional Rb-1 gene in murine development Nature 1992 359 6393 328 330
60. Donovan S. L., Schweers B., Martins R., Johnson D., Dyer M. A., Compensation by tumor suppressor genes during retinal development in mice and humans BMC Biology 2006 4, article no. 14
61. Robanus-Maandag E., Dekker M., Van Der Valk M., Carrozza M. L., Jeanny J. C., Dannenberg J. H., Berns A., Riele H. T., p107 is a suppressor of retinoblastoma development in pRB-deficient mice Genes and Development 1998 12 11 1599 1609 (Pubitemid 28299512)
62. Dannenberg J. H., Schuijff L., Dekker M., Van Der Valk M., Te Riele H., Tissue-specific tumor suppressor activity of retinoblastoma gene homologs p107 and p130 Genes and Development 2004 18 23 2952 2962 (Pubitemid 39602313)
63. Nielsen G. P., Burns K. L., Rosenberg A. E., Louis D. N., CDKN2A gene deletions and loss of p16 expression occur in osteosarcomas that lack RB alterations American Journal of Pathology 1998 153 1 159 163 (Pubitemid 28317518)
64. Shimizu T., Ishikawa T., Sugihara E., Kuninaka S., Miyamoto T., Mabuchi Y., Matsuzaki Y., Tsunoda T., Miya F., Morioka H., Nakayama R., Kobayashi E., Toyama Y., Kawai A., Ichikawa H., Hasegawa T., Okada S., Ito T., Ikeda Y., Suda T., Saya H., C-MYC overexpression with loss of Ink4a/Arf transforms bone marrow stromal cells into osteosarcoma accompanied by loss of adipogenesis Oncogene 2010 29 42 5687 5699
65. Cameron E. R., Neil J. C., The Runx genes: lineage-specific oncogenes and tumor suppressors Oncogene 2004 23 24 4308 4314 (Pubitemid 38758596)
66. Sadikovic B., Thorner P., Chilton-MacNeill S., Martin J. W., Cervigne N. K., Squire J., Zielenska M., Expression analysis of genes associated with human osteosarcoma tumors shows correlation of RUNX2 overexpression with poor response to chemotherapy BMC Cancer 2010 10, article 202
67. Won K. Y., Park H. R., Park Y. K., Prognostic implication of immunohistochemical Runx2 expression in osteosarcoma Tumori 2009 95 3 311 316
68. Thomas D. M., Carty S. A., Piscopo D. M., Lee J. S., Wang W. F., Forrester W. C., Hinds P. W., The retinoblastoma protein acts as a transcriptional coactivator required for osteogenic differentiation Molecular Cell 2001 8 2 303 316 (Pubitemid 32831548)
69. Thomas D. M., Johnson S. A., Sims N. A., Trivett M. K., Slavin J. L., Rubin B. P., Waring P., McArthur G. A., Walkley C. R., Holloway A. J., Diyagama D., Grim J. E., Clurman B. E., Bowtell D. D. L., Lee J. S., Gutierrez G. M., Piscopo D. M., Carty S. A., Hinds P. W., Terminal osteoblast differentiation, mediated by runx2 and p27, is disrupted in osteosarcoma Journal of Cell Biology 2004 167 5 925 934 (Pubitemid 39628114)
70. Gutierrez G. M., Kong E., Sabbagh Y., Brown N. E., Lee J. S., Demay M. B., Thomas D. M., Hinds P. W., Impaired bone development and increased mesenchymal progenitor cells in calvaria of RB1 mice Proceedings of the National Academy of Sciences of the United States of America 2008 105 47 18402 18407
71. Molyneux S. D., Di Grappa M. A., Beristain A. G., McKee T. D., Wai D. H., Paderova J., Kashyap M., Hu P., Maiuri T., Narala S. R., Stambolic V., Squire J., Penninger J., Sanchez O., Triche T. J., Wood G. A., Kirschner L. S., Khokha R., Prkar1a is an osteosarcoma tumor suppressor that defines a molecular subclass in mice Journal of Clinical Investigation 2010 120 9 3310 3325
72. Kansara M., Tsang M., Kodjabachian L., Sims N. A., Trivett M. K., Ehrich M., Dobrovic A., Slavin J., Choong P. F. M., Simmons P. J., Dawid I. B., Thomas D. M., Wnt inhibitory factor 1 is epigenetically silenced in human osteosarcoma, and targeted disruption accelerates osteosarcomagenesis in mice Journal of Clinical Investigation 2009 119 4 837 851
73. Chen W., Cooper T. K., Zahnow C. A., Overholtzer M., Zhao Z., Ladanyi M., Karp J. E., Gokgoz N., Wunder J. S., Andrulis I. L., Levine A. J., Mankowski J. L., Baylin S. B., Epigenetic and genetic loss of Hic1 function accentuates the role of p53 in tumorigenesis Cancer Cell 2004 6 4 387 398 (Pubitemid 39361439)
74. Aqeilan R. I., Trapasso F., Hussain S., Costinean S., Marshall D., Pekarsky Y., Hagan J. P., Zanesi N., Kaou M., Stein G. S., Lian J. B., Croce C. M., Targeted deletion of Wwox reveals a tumor suppressor function Proceedings of the National Academy of Sciences of the United States of America 2007 104 10 3949 3954 (Pubitemid 47181559)
75. Kurek K. C., Del Mare S., Salah Z., Abdeen S., Sadiq H., Lee S. H., Gaudio E., Zanesi N., Jones K. B., DeYoung B., Amir G., Gebhardt M., Warman M., Stein G. S., Stein J. L., Lian J. B., Aqeilan R. I., Frequent attenuation of the WWOX tumor suppressor in osteosarcoma is associated with increased tumorigenicity and aberrant RUNX2 expression Cancer Research 2010 70 13 5577 5586
76. McAnulty P. A., Skydsgaard M., Diethylstilbestrol (DES): carcinogenic potential in Xpa-/-,Xpa-/-/p53+/-, and wild-type mice during 9 months' dietary exposure Toxicologic Pathology 2005 33 5 609 620 (Pubitemid 41473097)
77. McAllister K. A., Houle C. D., Malphurs J., Ward T., Collins N. K., Gersch W., Wharey L., Seely J. C., Betz L., Bennett L. M., Wiseman R. W., Davis B. J., Spontaneous and irradiation-induced tumor susceptibility in BRCA2 germline mutant mice and cooperative effects with a p53 germline mutation Toxicologic Pathology 2006 34 2 187 198
78. Kuno T., Bilateral nonpalpable breast carcinomas in a patient with BRCA2 germ line mutation and past history of osteosarcoma Breast Cancer 1999 6 1 51 54
79. Mann M. B., Hodges C. A., Barnes E., Vogel H., Hassold T. J., Luo G., Defective sister-chromatid cohesion, aneuploidy and cancer predisposition in a mouse model of type II Rothmund-Thomson syndrome Human Molecular Genetics 2005 14 6 813 825 (Pubitemid 40403277)
80. Hoki Y., Araki R., Fujimori A., Ohhata T., Koseki H., Fukumura R., Nakamura M., Takahashi H., Noda Y., Kito S., Abe M., Growth retardation and skin abnormalities of the Recq14-deficient mouse Human Molecular Genetics 2003 12 18 2293 2299 (Pubitemid 37160873)
81. McClatchey A. I., Saotome I., Mercer K., Crowley D., Gusella J. F., Bronson R. T., Jacks T., Mice heterozygous for a mutation at the Nf2 tumor suppressor locus develop a range of highly metastatic tumors Genes and Development 1998 12 8 1121 1133 (Pubitemid 28194048)
82. Stemmer-Rachaminov A. O., Nielsen G. P., Rosenberg A. E., Louis D. N., Jones D., Ramesh V., Gusella J. F., Jacoby L. B., The NF2 gene and merlin protein in human osteosarcomas Neurogenetics 1998 2 1 73 74 (Pubitemid 29067537)
83. Lin P. P., Pandey M. K., Jin F., Raymond A. K., Akiyama H., Lozano G., Targeted mutation of p53 and Rb in mesenchymal cells of the limb bud produces sarcomas in mice Carcinogenesis 2009 30 10 1789 1795
84. Harvey M., McArthur M. J., Montgomery C. A., Bradley A., Donehower L. A., Genetic background alters the spectrum of tumors that develop in p53- deficient mice FASEB Journal 1993 7 10 938 943 (Pubitemid 23225552)
85. Oghiso Y., Yamada Y., The specific induction of osteosarcomas in different mouse strains after injections of 239Pu citrate Journal of Radiation Research 2003 44 2 125 132 (Pubitemid 38738740)
86. Pollak M., Sem A. W., Richard M., Tetenes E., Bell R., Inhibition of metastatic behavior of murine osteosarcoma by hypophysectomy Journal of the National Cancer Institute 1992 84 12 966 971
87. Deitel K., Dantzer D., Ferguson P., Pollak M., Beamer W., Andrulis I., Bell R., Reduced growth of human sarcoma xenografts in hosts homozygous for the lit mutation Journal of Surgical Oncology 2002 81 2 75 79
88. Hong S. H., Briggs J., Newman R., Hoffman K., Mendoza A., LeRoith D., Helman L., Yakar S., Khanna C., Murine osteosarcoma primary tumour growth and metastatic progression is maintained after marked suppression of serum insulin-like growth factor I International Journal of Cancer 2009 124 9 2042 2049
89. Vahle J. L., Sato M., Long G. G., Young J. K., Francis P. C., Engelhardt J. A., Westmore M. S., Ma Y. L., Nold J. B., Skeletal changes in rats given daily subcutaneous injections of recombinant human parathyroid hormone (1-34) for 2 years and relevance to human safety Toxicologic Pathology 2002 30 3 312 321 (Pubitemid 34556102)
90. Subbiah V., Madsen V. S., Raymond A. K., Benjamin R. S., Ludwig J. A., Of mice and men: divergent risks of teriparatide-induced osteosarcoma Osteoporosis International 2009 1 5
91. Alves De Oliveira E. C., Szejnfeld V. L., Pereira Da Silva N., Coelho Andrade L. E., Heldan De Moura Castro C., Intermittent PTH1-34 causes DNA and chromosome breaks in osteoblastic and nonosteoblastic cells Calcified Tissue International 2010 87 5 424 436
92. Jolette J., Wilker C. E., Smith S. Y., Doyle N., Hardisty J. F., Metcalfe A. J., Marriott T. B., Fox J., Wells D. S., Defining a noncarcinogenic dose of recombinant human parathyroid hormone 1-84 in a 2-year study in fischer 344 rats Toxicologic Pathology 2006 34 7 929 940 (Pubitemid 46011145)